Press Releases

Fluxion Biosciences announced that it has introduced F1 giga-ohm seal plates for the IonFlux automated patch clamp system. The newly launched F1 plates complement Fluxion’s existing 20-cell ensemble recording plates and are fully compatible with all IonFlux systems. Users...

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its ECLIPSE II Phase I/IIa study indicate that treatment with four weeks...

Eli Lilly and Company and Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration (FDA) has approved ERBITUX® (cetuximab), in combination with platinum-based chemotherapy with 5-fluorouracil (CT), for the first-line treatment of recurrent locoregional or metastatic squamous...

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today that the first patient has been treated in a phase II proof-of-concept study...

Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new treatments against proliferative diseases, today announces the presentation by Professor Tatjana Stankovic, from the University of Birmingham (UK) School...

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its ECLIPSE II Hepatitis C Phase I/IIa multicenter study will be presented...

CertiVox, an information security company, today announces it has received the Yearling category of the 2011 Bully Award, an honour presented by White Bull Summits to Europe’s leading technology, media and telecommunications (TMT) companies. The award...